You are here » Home » Companies » Company Overview » Core Healthcare Ltd

Core Healthcare Ltd.

BSE: 500091	Sector: Health care
NSE: COREPARENT	ISIN Code: INE494A01017

BSE 05:30 | 01 Jan

Core Healthcare Ltd

NSE 05:30 | 01 Jan

Core Healthcare Ltd

Core Healthcare Ltd. (COREPARENT) - News Sector

Weak US sales drags Lupin's Q1 show, revival hinges on key launches

12.01 am | 8 Aug 2020 | Business Standard

The company reported a sharp 21 per cent decline in revenues in the US, much higher than its peers
We are looking at vaccines as new growth pivot: Strides Pharma chief

11.35 pm | 7 Aug 2020 | Business Standard

In a Q&A, pharma major's MD & CEO, R Ananthanarayanan says the firm is setting up a vaccine suite and is in final-stage talks with global players to s...
Cipla Q1 pre-tax profit jumps 20% to Rs 799 crore on strong revenues

10.13 pm | 7 Aug 2020 | Business Standard

Firm's domestic business did well, up 16% YoY during the quarter when Cipla launched licensed version of Gilead's remdesivir
Alkem Labs Q1 profit jumps 2-fold to Rs 423.2 cr, revenue up at Rs 2,004 cr

6.09 pm | 7 Aug 2020 | Press Trust of India

Consolidated revenue from operations of the company stood at Rs 2,003.49 crore for the quarter under consideration. It was Rs 1,849.50 crore for the s...
Lupin plunges 6% as June quarter profit tanks 60% YoY to Rs 107 crore

10.18 am | 7 Aug 2020 | Business Standard

EBITDA tood at Rs 531.4 cror for the quarter under review, down 34.7 per cent, from Rs 813.4 crore of Q1FY20, and by 27.6 per from Rs 733.9 crore logg...
Stocks to watch: HPCL, Voda Idea, Mindspace REIT, Lupin, M&M, Cipla, Abbott

9.15 am | 7 Aug 2020 | Business Standard

Here's a list of stocks that may trade acively in today's trading session.
Nifty view and stock calls by Anand Rathi: Buy Glenmark Pharma, MPhasis

8.12 am | 7 Aug 2020 | Business Standard

Glenmark Pharma's stock is taking the support of a rising trend line
Novartis India Q1 net profit jumps over 5-fold to Rs 4.39 cr on price cuts

8.54 pm | 6 Aug 2020 | Press Trust of India

The company had posted a net profit of Rs 79 lakh in the corresponding period of previous fiscal
Lupin alliance partner Concord gets USFDA nod for generic medicine

5.48 pm | 6 Aug 2020 | Press Trust of India

Concord has received approval from the US Food and Drug Administration (USFDA) to market the drug to prevent organ transplant rejection
Glenmark to launch higher strength of FabiFlu to manage Covid-19 dosage

3.23 pm | 6 Aug 2020 | Press Trust of India

The higher strength will improve compliance for patients by effectively reducing the number of tablets required per day
Alkem Lab jumps 4.5% as it launches Favipiravir drug to treat Covid-19

10.42 am | 6 Aug 2020 | Business Standard

Alkem Laboratories has launched Favipiravir under the brand name 'Alfluenza' in India for the management of mild to moderate cases of Covid-19
Alkem Lab jumps 4.5% as it launches Favipiravir drug to treat Covid-19

10.42 am | 6 Aug 2020 | Business Standard

Alkem Laboratories has launched Favipiravir under the brand name 'Alfluenza' in India for the management of mild to moderate cases of Covid-19
US-led growth helps Cadila post steady Q1 show even as India biz falters

1.46 am | 6 Aug 2020 | Business Standard

While India business disappointed, lower expenses helped margins
Collaborating with govt agencies to develop treatment for Covid-19: Cipla

6.05 pm | 5 Aug 2020 | Press Trust of India

The company is offering drugs, which have shown potency in treating Covid-19, in partnership with its global partners
Cadila Healthcare slips 4.5% from day's high post June quarter results

2.03 pm | 5 Aug 2020 | Business Standard

The stock of the pharmaceutical firm declined 4.5 per cent from its intra-day high of Rs 411.60, also its 52-week high, touched earlier in the day.
Zydus Cadila to begin phase II Covid-19 vaccine clinical trials from Aug 6

12.03 pm | 5 Aug 2020 | Press Trust of India

Zydus Cadila Chairman Pankaj R Patel said the phase I dosing to establish the safety of ZyCoV-D is an important milestone
Weekly trading ideas by Religare Broking: Buy Bharti Airtel, Titan Company

8.27 am | 5 Aug 2020 | Business Standard

TITAN, after the breakout from a consolidation range, is gradually inching higher while holding strongly above the support zone of the long term movin...
Weekly trading ideas by Religare Broking: Buy Bharti Airtel, Titan Company

8.27 am | 5 Aug 2020 | Business Standard

TITAN, after the breakout from a consolidation range, is gradually inching higher while holding strongly above the support zone of the long term movin...
11,250 crucial for Nifty to negate bearish set-up: Vinay Rajani of HDFC Sec

8.06 am | 5 Aug 2020 | Business Standard

This sharp recovery could end up being a dead cat bounce, as the trend-line support which was recently broken could act as a resistance at 11,250
Lupin gets US FDA approval to market generic diabetes drug in the US

7.27 pm | 4 Aug 2020 | Press Trust of India

The Mumbai-based company has received a tentative approval from the USFDA for its Empagliflozin tablets